Cornerstone Pharmaceuticals-B (02616.HK) will showcase CS2015 (OX40L/TSLP bispecific antibody) at ACAAI 2025.

Capital Securities App News, cornerstone Pharmaceuticals-B (02616.HK) announced that one of the company's own immune and inflammation pipeline CS2015 (OX40L/TSLP bispecific antibody) has been selected for the 2025 annual scientific conference of the American College of Allergy, Asthma, and Immunology (ACAAI), and will be presented in the form of "electronic poster presentation + on-site oral presentation". The conference will take place in Orlando, USA from November 6th to 10th.